首页> 外文OA文献 >Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning
【2h】

Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning

机译:与调节性T细胞和血管化骨髓移植的联合治疗产生混合嵌合体并诱导供体特异性对血管化复合同种异体移植物的耐受性而无需细胞减灭条件化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We demonstrate herein that combination treatment with regulatory T cells (Tregs) and vascularized bone marrow transplantation (VBMT) can achieve stable mixed chimerism and long-term transplantation tolerance to vascularized composite allografts (VCA) without requiring cytoreductive recipient conditioning in rats. An appreciable number of Tregs of recipient origin was shown at the interface between recipient and transplanted VCA tissues, implicating a significant role for Tregs in protecting VCA from rejection. This cytoreduction-free protocol using co-treatment with Tregs and VBMT warrants further investigation toward potential clinical application for VCA transplantation.
机译:我们在本文中证明与调节性T细胞(Tregs)和血管化骨髓移植(VBMT)的联合治疗可以实现稳定的混合嵌合和对血管化复合同种异体移植物(VCA)的长期移植耐受性,而无需在大鼠中进行细胞还原受体调节。在受体和移植的VCA组织之间的界面处显示了相当数量的受体来源的Treg,这暗示了Treg在保护VCA免于排斥中的重要作用。这种与Tregs和VBMT共同治疗的无细胞减少方案值得进一步研究,以潜在地进行VCA移植的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号